Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: a month ago

Possible Interaction: Glucose and Vitamin D

supplement:

Glucose

supplement:

Vitamin D

Research Papers that Mention the Interaction

…,vitamin D … plasma glucose (FPG) (7.67 ± 7.66 versus 1.71 ± 7.50 mg/dL, p = .001) and significantly increased homeostasis model of assessment-estimated B … mg/dL, p = .001), and serum vitamin D level (28.24 ± 6.47 versus 3.55 ± 4.25 ng/mL, p = .001).
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology  •  2018  |  View Paper
vitamin D … plasma glucose (-7.5±10.6 vs. +0.3±10.7mg/dL, P=0.004), serum insulin levels (-3.6±5.3 vs. -0.9±…=0.001) and LDL-cholesterol (-11.1±17.9 vs. +5.9±27.5mg/dL, P=0.004) compared with the placebo.
Progress in Neuro-Psychopharmacology and Biological Psychiatry  •  2017  |  View Paper
Vitamin D … plasma glucose (-4.3±8.6 vs. -4.7±7.1 and +0.1±6.7 mg/dl, respectively, p=0.02), serum insulin concentrations (-….02), and HOMA-IR (-0.6±0.6 vs. -0.4±1.0 and -0.1±0.9, respectively, p=0.02).
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme  •  2017  |  View Paper
…,vitamin D … plasma glucose (-14.9 ± 7.1 compared with +19.3 ± 7.1 mg/dL; P = 0.001), serum insulin (-2.7 ± 1.1 compared with +… < 0.001) and the Quantitative Insulin Sensitivity Check Index (+0.008 ± 0.004 compared with -0.007 ± 0.004; P = 0.01).
The Journal of nutrition  •  2017  |  View Paper
…,vitamin D … plasma glucose (FPG) (-3.1±7.3 vs. +0.5±6.3 mg/dl, p=0.02), insulin (-1.4±3.6 vs. +2.6±…, p=0.005), and increased quantitative insulin sensitivity check index (+0.01±0.01 vs. -0.02±0.05, p=0.007).
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme  •  2017  |  View Paper
Multivariate regression revealed strong interaction of vitamin D with body mass index that resulted in increased fasting glucose (p = 0.001) and reduced homeostasis model assessment of β-cell function (HOMA-B; p = 0.01) in normoglycemic individuals.
Annals of nutrition & metabolism  •  2017  |  View Paper
There was a significant interaction between non-Hispanic whites and Mexican Americans combined, compared with non-Hispanic blacks, when 25(OH)D was regressed against fasting glucose (p=0.016) but not against fasting insulin (p>0.05).
The Journal of Steroid Biochemistry and Molecular Biology  •  2016  |  View Paper
Vitamin D significantly reduced fasting plasma glucose and HbA1c levels.
Diabetic medicine : a journal of the British Diabetic Association  •  2016  |  View Paper
25(OH)D levels correlated negatively with homeostasis model of assessment for insulin resistance (HOMA-IR) (r = -0.200; P = .032) and glucose (r = -0.295; P = .001), but not with BMI.
The Journal of clinical endocrinology and metabolism  •  2015  |  View Paper
Among RCTs, compared … placebo, vitamin D supplementation was associated with significant decrease in fasting glucose [SMD −1.13, (−2.11 to −0.11)] and PTH levels [SMD −1.50, (−2.95 to −0.04)] but no difference in fasting insulin levels [SMD 1.32, (−0.15 to 2.79)].
International Urology and Nephrology  •  2015  |  View Paper
Show More